Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (31-40 of 743) with videos related to

Pageof 75
Sort By:
Current Opinion in Oncology|February 10, 2012
Resistance patterns with tyrosine kinase inhibitors in melanoma: new insightsReinhard Dummer, Keith T Flaherty
Oncoimmunology|September 20, 2018
Immunological effects of BRAF+MEK inhibitionPaolo A Ascierto, Reinhard Dummer
Current Opinion in Oncology|January 23, 2018
Development of encorafenib for BRAF-mutated advanced melanomaPeter Koelblinger, Olaf Thuerigen, Reinhard Dummer
European Journal of Cancer (Oxford, England : 1990)|October 3, 2017
The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patientsAlexander M M Eggermont, Reinhard Dummer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 6, 2007
Cutaneous lymphomasReinhard Dummer, Rudolf Stadler, Wolfram Sterry
Archives of Dermatological Research|October 9, 2007
Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimodMaja Wuest, Reinhard Dummer, Mirjana Urosevic
Archives of Dermatology|March 23, 2005
Dyscrasias with "undetermined significance"Günter Burg, Reinhard Dummer, Werner Kempf
Experimental Dermatology|April 25, 2006
Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?Reinhard Dummer, Antonio Cozzio, Mirjana Urosevic
Expert Opinion on Investigational Drugs|August 10, 2019
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an updateEgle Ramelyte, Reinhard Dummer, Emmanuella Guenova
Future Oncology (London, England)|June 8, 2017
A review of binimetinib for the treatment of mutant cutaneous melanomaPeter Koelblinger, Joelle Dornbierer, Reinhard Dummer
Pageof 75

Showing results (31-40 of 743) with videos related to

Sort By:
Pageof 75
Current Opinion in Oncology|February 10, 2012
Resistance patterns with tyrosine kinase inhibitors in melanoma: new insightsReinhard Dummer, Keith T Flaherty
Oncoimmunology|September 20, 2018
Immunological effects of BRAF+MEK inhibitionPaolo A Ascierto, Reinhard Dummer
Current Opinion in Oncology|January 23, 2018
Development of encorafenib for BRAF-mutated advanced melanomaPeter Koelblinger, Olaf Thuerigen, Reinhard Dummer
European Journal of Cancer (Oxford, England : 1990)|October 3, 2017
The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patientsAlexander M M Eggermont, Reinhard Dummer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 6, 2007
Cutaneous lymphomasReinhard Dummer, Rudolf Stadler, Wolfram Sterry
Archives of Dermatological Research|October 9, 2007
Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimodMaja Wuest, Reinhard Dummer, Mirjana Urosevic
Archives of Dermatology|March 23, 2005
Dyscrasias with "undetermined significance"Günter Burg, Reinhard Dummer, Werner Kempf
Experimental Dermatology|April 25, 2006
Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?Reinhard Dummer, Antonio Cozzio, Mirjana Urosevic
Expert Opinion on Investigational Drugs|August 10, 2019
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an updateEgle Ramelyte, Reinhard Dummer, Emmanuella Guenova
Future Oncology (London, England)|June 8, 2017
A review of binimetinib for the treatment of mutant cutaneous melanomaPeter Koelblinger, Joelle Dornbierer, Reinhard Dummer
Pageof 75